PharmaRoth Labs, Inc. Share Price Other OTC
Equities
ROTH
US71715Y1029
Pharmaceuticals
Sales 2009 | - | Sales 2010 | - | Capitalization | 5.74M 451M |
---|---|---|---|---|---|
Net income 2009 | - 0 | Net income 2010 | - 0 | EV / Sales 2009 | - |
Net Debt 2009 | 12.5K 984K | Net Debt 2010 | 286K 22.52M | EV / Sales 2010 | - |
P/E ratio 2009 |
-777
x | P/E ratio 2010 |
-7.8
x | Employees | - |
Yield 2009 * |
-
| Yield 2010 |
-
| Free-Float | 30.93% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 30/08/10 | |
Barry W. Hall
DFI | Director of Finance/CFO | 76 | 21/01/13 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 30/08/10 |
1st Jan change | Capi. | |
---|---|---|
+34.35% | 693B | |
+29.39% | 584B | |
-3.49% | 372B | |
+20.15% | 332B | |
+6.19% | 294B | |
+14.11% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+9.21% | 168B |